Coya Therapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:COYA) | MetaTrader

Tam grafiği aç Full chart

Haberler

Coya Therapeutics’in ALS tedavisi FDA’den hızlı onay aldı

Coya Therapeutics’te kurucusu görevinden ayrıldı, yeni yönetici atandı

ReAlta Life Sciences, Berman’ı CEO, Motesharei’yi başkan yaptı

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright, Coya Therapeutics hissesi için Al notunu 18 dolar hedefiyle yineledi

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics özel yerleşimde 11,1 milyon dolar sağladı

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright, Coya Therapeutics hissesi için Al tavsiyesini 18 dolar hedefle yineledi

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18